Skip to main content
. 2013 May 17;62(19):377–381.

TABLE 1.

Number and percentage of patients with fungal spinal or paraspinal infections with and without meningitis who received contaminated methylprednisolone acetate injections, by sex and clinical characteristics — Michigan, 2012

Characteristic All patients (N = 180) Spinal or paraspinal infections with meningitis (n = 39) Spinal or paraspinal infections without meningitis (n = 141)



No. (%) No. (%) No. (%)
Sex
 Male 75 (42) 14 (36) 61 (43)
 Female 105 (58) 25 (64) 80 (57)
Signs and symptoms of spinal or paraspinal infection (n = 178) (n = 39) (n = 139)
 Fever/chills 13 (7) 6 (15) 7 (5)
 Headache 77 (43) 28 (72) 49 (35)
 Slurred speech 2 (1) 0 2 (1)
 Confusion 8 (4) 4 (10) 4 (3)
 Light sensitivity 21 (12) 12 (31) 9 (6)
 Nausea/vomiting 39 (22) 18 (46) 21 (15)
 Neck pain/stiff neck 42 (24) 13 (33) 29 (21)
 Back pain 116 (65) 18 (46) 98 (71)
 Leg pain 12 (7) 0 12 (9)
 Urinary retention 4 (2) 0 4 (3)
 Urinary incontinence 2 (1) 0 2 (1)
 Ataxia 1 (1) 0 1 (1)
 Visual disturbance 6 (3) 3 (8) 3 (2)
 Numbness 10 (6) 2 (5) 8 (6)
 Meningeal signs* 7 (4) 6 (15) 1 (1)
 Laboratory confirmation of fungal infection 57 (32) 20 (51) 37 (26)
*

Including nuchal rigidity, Kernig sign, and Brudzinski sign.

Confirmation by culture, polymerase chain reaction, or histopathology.